7 Life Science Stocks to Sell

Health care is a recession-proof sector since many patients have no choice but
to undergo treatments no matter what the broader economy is like even if those
cures are often expensive. That adds up to a stable customer base for most
companies. However, don't be fooled into thinking every health stock is a
great buy. A number of life sciences companies are struggling and have seen
shares sell off sharply in recent months. I watch more than 5,000 publicly
traded companies with my Portfolio Grader tool, ranking companies by a number of
fundamental and quantitative measures. This week, Ive got seven life science
stocks to sell. Here they are, in alphabetical order. Each one of these stocks
gets a "D" or "F" according to my research, meaning it is a "sell"
or "strong sell." Bruker Corp. (NASDAQ: BRKR ) develops scientific
instruments for use in the life science, pharmaceutical, biotechnology, clinical
and molecular diagnostics research fields. BRKR stock is down 23% since Jan. 1.
Charles River Laboratories International Inc. (NYSE: CRL ) develops solutions
that accelerate the drug discovery and development process. Like other life
sciences stocks, CRL is down nearly 21% year-to-date. Icon (NASDAQ: ICLR )
provides services, internationally, to the pharmaceutical, biotechnology and
medical device industries. A drop of 24% year-to-date has ensured ICLR stock a
spot on this list. Illumina Inc. (NASDAQ: ILMN ) is involved with various
genetic analysis solutions, including sequencing, genotyping, gene expression
and molecular diagnostics. ILMN stock has posted an incredible loss of 56% in
just the last 11 months. Life Technologies Corp. (NASDAQ: LIFE ) is a global
life services company that develops a wide range of products and services. LIFE
stock is down 29%, year-to-date. PerkinElmer Inc. (NYSE: PKI ) works closely
with the diagnostics, research, environmental and safety, industrial and
laboratory services markets. PKI stock has lost 26% year-to-date, compared to
only slight losses by the broader markets in the same time frame. Qiagen
(NASDAQ: QGEN ) has developed more than 500 consumable products and automated
solutions used for a variety of solutions.